Tedizolid Phophate + Antibiotic comparator + Aztreonam + Metronidazole
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Skin Diseases, Infectious
Conditions
Skin Diseases, Infectious, Skin Diseases, Bacterial
Trial Timeline
Mar 25, 2015 → Sep 17, 2018
NCT ID
NCT02276482About Tedizolid Phophate + Antibiotic comparator + Aztreonam + Metronidazole
Tedizolid Phophate + Antibiotic comparator + Aztreonam + Metronidazole is a phase 3 stage product being developed by Merck for Skin Diseases, Infectious. The current trial status is completed. This product is registered under clinical trial identifier NCT02276482. Target conditions include Skin Diseases, Infectious, Skin Diseases, Bacterial.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02276482 | Phase 3 | Completed |
Competing Products
20 competing products in Skin Diseases, Infectious